In preparing for this year’s annual outlook issue (published in December), Life Science Leader posed a variety of questions to biopharmaceutical executives. Unfortunately, not all the responses could be squeezed into the annual outlook print edition, so we decided to share them here. Don’t miss out on all the other knowledge and wisdom provided by the more […]

A Tampa cancer analytics company is teaming with one of the world’s biggest tech giants to expand the scope of its data collection and processing — and potentially help researchers develop new treatments. M2Gen, which formed in 2006 out of a for-profit partnership between the Moffitt Cancer Center and Merck & Co., has reached a […]

DocWire News spoke with Jim Joyce, Co-Founder, Chairman, and CEO of Sigyn Therapeutics, a developmental technology company focused on treatments for life-threatening inflammatory conditions precipitated by the Cytokine Storm Syndrome, a dangerous immune response that can be initiated by a wide-range of infectious and non-infectious conditions, including COVID-19. Mr. Joyce discussed the benefits of blood purification […]